InsidersTradesSigma
Follow the NOXOPHARM LIMITED stock price and the full insider trade history of the company, a publicly traded company based in Australia. Shares trade on AU AU, under the supervision of ASX. Market capitalisation: €26.4m. The latest transaction was disclosed on 1 June 2026 (Other). Among the most active insiders: Unknown. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
NOXOPHARM LIMITED is a biopharmaceutical company focused on developing treatments for cancer and other serious diseases. It is listed on the XASX market.